197 Results

People

  1. Ladanyi
    Ladanyi
  2. Kris
    Kris
  3. Riely
    Riely
  4. Solit
    Solit
  5. Arcila
    Arcila
  6. O'Reilly
    O'Reilly
  7. Rusch
    Rusch
  8. Schultz
    Schultz
  9. Basturk
    Basturk
  10. Shia
    Shia

Groups

  1. Department of Medicine (115)
  2. Solid Tumor Oncology Division (105)
  3. GSK Faculty (92)
  4. Department of Pathology and Laboratory Medicine (77)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (54)
  7. Center for Pancreatic Cancer Research (49)
  8. Thoracic Oncology (47)
  9. Gastrointestinal Oncology Service (43)
  10. Tow Center for Developmental Oncology (TCDO) (43)
  1. "k ras protein"
Formats
  1. Journal Article (182)
  2. Review (10)
  3. Editorial (4)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (115)
  2. Solid Tumor Oncology Division (105)
  3. GSK Faculty (92)
  4. Department of Pathology and Laboratory Medicine (77)
  5. Human Oncology and Pathogenesis Program (66)
  6. Surgery (54)

More Groups

People
  1. Marc Ladanyi (32)
  2. Mark Kris (24)
  3. Gregory Riely (21)
  4. David Solit (16)
  5. Maria Arcila (13)
  6. Maureen Zakowski (13)

More People

Years
  1. 2025 (14)
  2. 2024 (23)
  3. 2023 (11)
  4. 2022 (6)
  5. 2021 (4)
  6. 2020 (14)

More Years

Publications
  1. Clinical Cancer Research (12)
  2. Journal of Thoracic Oncology (10)
  3. Proceedings of the National Academy of Sciences of the United States of America (8)
  4. Cancer Cell (7)
  5. Modern Pathology (7)
  6. Journal of Clinical Oncology (6)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. American Association for Cancer Research (24)
  3. Cell Press (14)
  4. Wiley Blackwell (14)
  5. Nature Publishing Group (13)
  6. Lippincott Williams & Wilkins (12)

More Publishers

Results (197)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cooperative loss of RAS feedback regulation drives myeloid leukemogenesis
    Journal Article

    Zhao, Z.; Chen, C. C.; Rillahan, C. D.; Shen, R.; Kitzing, T.; McNerney, M. E.; Diaz-Flores, E.; Zuber, J.; Shannon, K.; Le Beau, M. M.; more...
    Nature Genetics (2015)

    Fulltext@MSK | Save
  • MAP2K1 (MEK1) mutations define a distinct subset of lung adenocarcinoma associated with smoking
    Journal Article

    Arcila, M. E.; Drilon, A.; Sylvester, B. E.; Lovly, C. M.; Borsu, L.; Reva, B.; Kris, M. G.; Solit, D. B.; Ladanyi, M.
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Biomarker-driven studies in metastatic colorectal cancer (mCRC): Challenges and opportunities
    Journal Article

    Van Cutsem, E.; Prager, G.; Sargent, D.; Byrne, A. T.; Huber, H. J.; Middleton, G.; Khan, K.; De Mattos-Arruda, L.; Seufferlein, T.
    Journal of OncoPathology (2014)

    Fulltext@MSK | Save
  • Integrated genomic characterization of papillary thyroid carcinoma
    Journal Article

    The Cancer Genome Atlas Research Network
    Cell (2014)

    Fulltext@MSK | Save
  • Altered transcriptional control networks with trans-differentiation of isogenic mutant-KRas NSCLC models
    Journal Article

    Haley, J. A.; Haughney, E.; Ullman, E.; Bean, J.; Haley, J. D.; Fink, M. Y.
    Frontiers in Oncology (2014)

    Fulltext@MSK | Save
  • Ganetespib, a novel Hsp90 inhibitor in patients with KRAS mutated and wild type, refractory metastatic colorectal cancer
    Journal Article

    Cercek, A.; Shia, J.; Gollub, M.; Chou, J. F.; Capanu, M.; Raasch, P.; Reidy-Lagunes, D.; Proia, D. A.; Vakiani, E.; Solit, D. B.; more...
    Clinical Colorectal Cancer (2014)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes
    Journal Article

    Chmielecki, J.; Hutchinson, K. E.; Frampton, G. M.; Chalmers, Z. R.; Johnson, A.; Shi, C.; Elvin, J.; Ali, S. M.; Ross, J. S.; Basturk, O.; more...
    Cancer Discovery (2014)

    Fulltext@MSK | Save
  • Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation
    Journal Article

    Chaft, J. E.; Litvak, A.; Arcila, M. E.; Patel, P.; D'Angelo, S. P.; Krug, L. M.; Rusch, V.; Mattson, A.; Coeshott, C.; Park, B.; more...
    Clinical Lung Cancer (2014)

    Fulltext@MSK | Save
  • CpG island methylator phenotype is associated with response to adjuvant irinotecan-based therapy for stage III colon cancer
    Journal Article

    Shiovitz, S.; Bertagnolli, M. M.; Renfro, L. A.; Nam, E.; Foster, N. R.; Dzieciatkowski, S.; Luo, Y.; Lao, V. V.; Monnat, R. J. Jr; Emond, M. J.; more...
    Gastroenterology (2014)

    Fulltext@MSK | Save
  • KRasG12D-evoked leukemogenesis does not require β-catenin
    Journal Article

    Ng, C. E. L.; Sinha, A.; Krivtsov, A.; Dias, S.; Chang, J.; Armstrong, S. A.; Kalaitzidis, D.
    Leukemia (2014)

    Fulltext@MSK | Save